Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
- PMID: 40879708
- DOI: 10.1007/s12664-025-01864-7
Revisiting thiopurines and therapeutic drug monitoring in IBD: Insights and implications in the Indian context
Conflict of interest statement
Declarations. Conflict of interest: Ajit Sood received honorarium for speaker events from Pfizer India and Takeda India. Arshdeep Singh has no conflicts. Disclaimer: The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Similar articles
-
Therapeutic Drug Monitoring and Pharmacogenomics of Thiopurines in Inflammatory Bowel Disease: International Guidelines Revisited.Ther Drug Monit. 2025 Aug 29. doi: 10.1097/FTD.0000000000001373. Online ahead of print. Ther Drug Monit. 2025. PMID: 40879507
-
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience.Pharmacogenomics. 2024;25(16-18):679-688. doi: 10.1080/14622416.2025.2463866. Epub 2025 Feb 16. Pharmacogenomics. 2024. PMID: 39957149
-
Clinical utility of thiopurine metabolite levels in monitoring patients with inflammatory bowel disease: A single-centre retrospective study.Indian J Gastroenterol. 2025 Jul 19. doi: 10.1007/s12664-025-01831-2. Online ahead of print. Indian J Gastroenterol. 2025. PMID: 40682730
-
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.Clin Gastroenterol Hepatol. 2011 Jan;9(1):36-41.e1. doi: 10.1016/j.cgh.2010.09.016. Epub 2010 Oct 1. Clin Gastroenterol Hepatol. 2011. PMID: 20888436
-
Systematic review with meta-analysis: inflammatory bowel disease in the elderly.Aliment Pharmacol Ther. 2014 Mar;39(5):459-77. doi: 10.1111/apt.12616. Epub 2014 Jan 9. Aliment Pharmacol Ther. 2014. PMID: 24405149
References
-
- Ranjan MK, Kumar P, Vuyyuru SK, et al. Thiopurines have sustained long-term effectiveness in patients with inflammatory bowel disease, which is independent of disease duration at initiation: a propensity score matched analysis. J Crohns Colitis. 2024;18:192–203. https://doi.org/10.1093/ecco-jcc/jjad135 . - DOI - PubMed
-
- Sood A, Kaur K, Singh A, et al. Trends of inflammatory bowel disease at a tertiary care center in northern India. Intest Res. 2021;19:282–90. https://doi.org/10.5217/ir.2020.00010 .
-
- Sood A, Ahuja V, Midha V, et al. Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intest Res. 2020;18:355–78. https://doi.org/10.5217/ir.2019.09176 . - DOI - PubMed - PMC
-
- Sood A, Midha V, Sood N, Bansal M. Long term results of use of azathioprine in patients with ulcerative colitis in India. World J Gastroenterol. 2006;12:7332–6. https://doi.org/10.3748/wjg.v12.i45.7332 . - DOI - PubMed - PMC
-
- Sood A, Midha V, Sood N, Avasthi G. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. Indian J Gastroenterol. 2003;22:79–81.
Publication types
LinkOut - more resources
Full Text Sources